You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Molecular Tumour Board

Showing 1 - 25 of 8,210
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Cancer Trial (Treatment recommendations made by Molecular Tumor Board.)

Not yet recruiting
  • Cancer
  • Treatment recommendations made by Molecular Tumor Board.
  • (no location specified)
Aug 9, 2022

Hematologic Tumors, Solid Tumor Trial in Madison (PMMTB (Precision Medicine Molecular Tumor Board))

Recruiting
  • Hematologic Neoplasms
  • Solid Neoplasm
  • PMMTB (Precision Medicine Molecular Tumor Board)
  • Madison, Wisconsin
    University of Wisconsin Carbone Cancer Center
Jul 7, 2022

Sarcoma Trial in Rome

Recruiting
  • Sarcoma
    • Rome, Italy
      "Regina Elena" National Cancer Institute
    Oct 6, 2023

    NSCLC Trial in Lexington (Molecular tumor board assisted care)

    Recruiting
    • Non-Small Cell Lung Cancer
    • Molecular tumor board assisted care
    • Lexington, Kentucky
      University of Kentucky
    Apr 13, 2022

    Biliary Tract Cancer Trial in Montréal (Tumour and germline molecular profiling)

    Recruiting
    • Biliary Tract Cancer
    • Tumour and germline molecular profiling
    • Montréal, Quebec, Canada
      McGill University Health Centre
    Nov 2, 2022

    Glioma Trial in London (Advanced MRI sequences)

    Not yet recruiting
    • Glioma
    • Advanced MRI sequences
    • London, United Kingdom
      King's R&I department
    Feb 22, 2022

    Usability of Cellworks Singula™ and Cellworks Ventura™ Reports

    Recruiting
    • Cancer
    • +2 more
    • Cellworks Report
    • Sioux Falls, South Dakota
      Avera Cancer Institute
    Jan 20, 2023

    Physician and Molecular Tumor Board Perspectives on Clinical

    Recruiting
    • Pan-cancer
    • Cellworks Singula and Ventura reports
    • Sioux Falls, South Dakota
      Avera McKennan
    Apr 1, 2022

    Cancer Trial in Lexington (Therapeutic Intervention)

    Recruiting
    • Cancer
    • Therapeutic Intervention
    • Lexington, Kentucky
      Markey Cancer Center, University of Kentucky
    Nov 18, 2022

    Upper GI Serial Tumour Biopsies

    Recruiting
    • Oesophageal Cancer
    • Gastric Cancer
    • Minor endoscopic biopsy
    • Manchester, Greater Manchester, United Kingdom
      The Christie Hospital NHS Foundation Trust
    May 3, 2022

    Centralized Tumour Board and Secondary Intervention Rate in mCRC

    Not yet recruiting
    • Metastatic Colorectal Cancer
    • +3 more
    • Virtual centralized multidisciplinary tumour board
    • (no location specified)
    Apr 15, 2021

    ER+ Breast Cancer, HER2-negative Breast Cancer Trial in Christchurch, London, Oxford (Palbociclib 125Mg Tab, Fulvestrant

    Recruiting
    • ER+ Breast Cancer
    • HER2-negative Breast Cancer
    • Palbociclib 125Mg Tab
    • +5 more
    • Christchurch, United Kingdom
    • +3 more
    May 19, 2022

    Prostate Cancer, Metastatic Castration-resistant Prostate Cancer, mCRPC Trial in Glen Burnie (177Lu-rhPSMA-10.1 injection,

    Recruiting
    • Prostate Cancer
    • +5 more
    • 177Lu-rhPSMA-10.1 injection
    • 18F-rhPSMA-7.3 injection
    • Glen Burnie, Maryland
    • +3 more
    Feb 2, 2023

    Diffuse Intrinsic Pontine Glioma (DIPG) Trial in United States (Specialized tumor board recommendation, Standard radiation

    Completed
    • Diffuse Intrinsic Pontine Glioma (DIPG)
    • Specialized tumor board recommendation
    • Standard radiation therapy
    • San Diego, California
    • +4 more
    Nov 2, 2022

    Guide Experimental Targeted Therapy - National

    Recruiting
    • Cancer
      • Belfast, United Kingdom
      • +19 more
      Aug 23, 2022

      Biliary Tract Tumors Trial in Belgium, France, United Kingdom (Futibatinib, Ivosidenib, Zanidatamab)

      Not yet recruiting
      • Biliary Tract Neoplasms
      • Brussels, Belgium
      • +56 more
      Nov 7, 2022

      Recurrent High Grade Glioma Trial (Receiving chemotherapeutic or targeted drugs recommended by molecular tumor board.)

      Not yet recruiting
      • Recurrent High Grade Glioma
      • Receiving chemotherapeutic or targeted drugs recommended by molecular tumor board.
      • (no location specified)
      Jul 21, 2022

      Cancer Metastatic Trial in Norway (Atezolizumab)

      Recruiting
      • Cancer Metastatic
      • Bergen, Norway
      • +16 more
      Oct 24, 2022

      Gynecologic Cancer Trial in Toronto (Tumour tissue collection, Blood draws)

      Recruiting
      • Gynecologic Cancer
      • Tumour tissue collection
      • Blood draws
      • Toronto, Ontario, Canada
        Princess Margaret Cancer Centre
      Nov 22, 2021

      Locally Advanced Carcinoma, Metastatic Cancer Trial in Austria (Next Generation Sequencing, Biomarker Monitoring)

      Recruiting
      • Locally Advanced Carcinoma
      • Metastatic Cancer
      • Next Generation Sequencing
      • Biomarker Monitoring
      • Innsbruck, Tirol, Austria
      • +4 more
      Mar 10, 2022

      Preoperative Molecular Diagnosis of Uterine Tumors by Liquid

      Recruiting
      • Leiomyoma, Uterine
      • Leiomyosarcoma Uterus
      • Collection of Leiomyoma samples
      • +2 more
      • L´Hospitalet de Llobregat, Barcelona, Spain
      • +20 more
      Sep 2, 2021

      Advanced / Metastic Solid Tumors, Glioblastoma, Chronic Leukemia Lymphocytic Trial in Bron, Lyon (Blood and tumor samples)

      Recruiting
      • Advanced / Metastic Solid Tumors
      • +2 more
      • Blood and tumor samples
      • Bron, France
      • +1 more
      Jun 30, 2022

      Cutaneous Squamous Cell Carcinoma, Cutaneous Squamous Cell Carcinoma of the Head and Neck, Tumors Trial in Melbourne

      Not yet recruiting
      • Cutaneous Squamous Cell Carcinoma
      • +3 more
      • Melbourne, Victoria, Australia
        Peter MacCallum Cancer Centre
      May 17, 2023

      Q-GAIN

      Recruiting
      • Gastrointestinal Cancer
      • QPOP
      • Singapore, Singapore
        National University Hospital
      Apr 4, 2022

      Lung Cancer, Primary Tumor, Metastases Trial in Tønsberg (Genome analysis of tissue samples.)

      Active, not recruiting
      • Lung Cancer
      • +2 more
      • Genome analysis of tissue samples.
      • Tønsberg, Norway
        Vestfold Hospital Trust
      Jan 19, 2023